History
  • No items yet
midpage
303 F. Supp. 3d 690
E.D. Ill.
2018
Read the full case

Background

  • Janice Keen, a long‑time pharmaceutical sales rep, suffered multiple work‑related injuries (2010 onward), took repeated medical/FMLA leaves, and requested accommodations (modified territory, limited lifting, altered schedule).
  • Teva (acquirer of Cephalon) reviewed title reclassifications and denied Keen promotion to Senior Executive Sales Specialist (SESS), citing lack of demonstrated leadership/mentorship despite meeting objective metrics.
  • Keen returned to work intermittently (2013, 2014), had performance criticisms and reduced incentive pay tied to leave policies, and disputed allocation errors and administrative shortcomings.
  • In 2015–2016 Keen again went on extended medical leave after surgeries; disputes arose over medical clearances, Work Care communications, disability/workers’ compensation benefits, company car/COBRA, and surveillance; Teva ultimately terminated her in April 2016.
  • Keen filed numerous administrative charges (EEOC/IDHR/IWCC) and sued Teva asserting 37 counts: ADA/IHRA disability discrimination and failure to accommodate, Title VII/IHRA sex discrimination, retaliation (federal and state), IWA claims, and retaliatory discharge. Defendants moved for summary judgment; the court granted it in full and denied sanctions/strike motion.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Intentional disability discrimination (including termination) Keen says adverse actions (delayed returns, denial of promotion, bonuses, adverse reviews, removal of car, termination) were caused "but for" her disability Teva contends actions were legitimate, nondiscriminatory business decisions: medical‑fitness concerns, neutral promotion criteria, leave/bonus/car/COBRA policies, and plaintiff was not a "qualified individual" due to prolonged inability to work Court: Summary judgment for Teva; Plaintiff failed to show "but for" causation or pretext; at termination Keen was not a qualified individual because of indefinite/prolonged leave
Failure to accommodate (return 2013; territory modification) Keen alleges Teva delayed/denied reasonable accommodations and refused territory modification required by her doctors Teva argues it engaged in interactive process, required medical clarification, legitimately delayed pending surgery/clearance, and denied territory change after lack of clinical documentation/cooperation Court: Summary judgment for Teva; record shows processes, requests for clarification, plaintiff impeded the interactive process and failed to present treating‑physician documentation supporting territory change
Gender discrimination (Title VII/IHRA) Keen alleges men were promoted/treated more favorably and she was denied benefits/promotions because she is female Teva says promotion denials were based on subjective leadership criteria and other contested benefits were discretionary or tied to neutral policies; comparators not similarly situated Court: Summary judgment for Teva; plaintiff failed to identify adequate comparators or evidence of pretext linked to sex
Retaliation (federal statutes, IWA, and retaliatory discharge under Illinois law) Keen contends adverse acts followed her EEOC/IDHR/IWCC complaints and thus were retaliatory Teva maintains no causal link: actions driven by policies, legitimate reasons, and timing/communications do not show motivating retaliatory animus Court: Summary judgment for Teva; plaintiff produced no direct evidence or a convincing mosaic of circumstantial evidence tying protected activity to adverse actions

Key Cases Cited

  • Celotex Corp. v. Catrett, 477 U.S. 317 (summary judgment standard)
  • Anderson v. Liberty Lobby, Inc., 477 U.S. 242 (jury credibility and summary judgment principles)
  • Nassar v. Univ. of Tex. Sw. Med. Ctr., 570 U.S. 338 (Title VII retaliation requires but‑for causation)
  • Severson v. Heartland Woodcraft, Inc., 872 F.3d 476 (ADA does not guarantee leave entitlement; prolonged leave defeats "qualified individual" status)
  • Monroe v. Indiana Dep't of Transp., 871 F.3d 495 (ADA causation/but‑for standard)
  • Teruggi v. CIT Grp./Capital Fin., Inc., 709 F.3d 654 (circumstantial evidence patterns for discrimination)
  • Ortiz v. Werner Enters., Inc., 834 F.3d 760 (overall standard: whether evidence permits a reasonable factfinder to conclude protected characteristic caused adverse action)
  • Ennin v. CNH Indus. Am., LLC, 878 F.3d 590 (pretext requires more than mistaken reasoning; must show lie)
  • Hoppe v. Lewis Univ., 692 F.3d 833 (failure‑to‑accommodate/interactive process principles)
Read the full case

Case Details

Case Name: Keen v. Teva Sales & Mktg., Inc.
Court Name: District Court, E.D. Illinois
Date Published: Mar 20, 2018
Citations: 303 F. Supp. 3d 690; No. 16 C 9964
Docket Number: No. 16 C 9964
Court Abbreviation: E.D. Ill.
Log In
    Keen v. Teva Sales & Mktg., Inc., 303 F. Supp. 3d 690